Nithya Alagappan

Healthcare Market Research Consultancy (Asian global insights partner for health and life science companies that optimizes commercialization success through evidence-based Insights and strategic recommendations)

• Headed fieldwork for 3 regional projects that generated at least 150,000 USD each among other country-level projects
• Designed and conducted pre-launch market understanding and customer segmentation studies to enable clients to identify most suitable marketing strategy for biggest blockbuster biologic drug in Oncology (yearly sales of ~USD 17 million in 2021)
• Determined optimal price point for a novel hyperkalemia treatment through Gabor-granger pricing model substantiated it with qualitative insights from senior doctors on the perceived value of client’s drug
• Condensed key findings from qualitative and quantitative studies into powerpoint presentations and presented actionable insights and recommendations to marketing directors and brand managers from pharmaceutical companies with more than USD 20 billion annual revenue.

AI-based Regulatory Consulting Startup (AI-based digital platform for regulatory affairs in Pharma, Biotech, Medical Devices and other industries)

• Demonstrated relationship management & consultative selling aptitude as key account manager for 2 largest clients in the company, signing new projects worth 10% of company revenue within 2 months
• Analysed historical sales and developed new sales strategy to increase sales by 40% in 2021
• Organised and led customer satisfaction feedback meetings for team of 12, including C-level executives
• Streamlined services provided to clients and created SOP for business development team which enabled semi-automation of internal business development process, reducing time taken for Request for Proposal to Project Signing by 50%

Boutique Life Science venture capital and consulting firm for biotech start-ups

• Acted as primary liaison for long-term clients from Japan and Europe and led and moderated meetings with CEOs and Board Chairman of companies
• Conducted market research and due diligence on a variety of Life Science startups with breakthrough technology in hot areas such as SaaS platform for genomic analyses, biologics manufacturing, life science research instruments, first-in-class therapeutics etc
• Generated leads for portfolio company by identifying KOLs in Structural Biology as clients to sell a novel Life Science research instrument to measure protein-nucleic acid/protein- protein interactions which secured 300,000 USD of revenue in Asia
• Performed horizon scanning to identify large Japanese Corporations planning strategic expansion in Life Sciences sector as potential partners for European portfolio companies in Asia which lead to management-level discussions on potential partnership
• Spearheaded a team of analysts in formulating a pitch deck presentation and investment memorandum for a Dutch cell therapy company treating Acute Myeloid Leukemia that led to successful closing of a €9 million funding round